Hypertension News
Hypertension. Read about the latest medical research on reducing high blood pressure, treatment options for hypertension and more.
-
Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk
A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Researchers say these medications could become a major weapon against cardiovascular disease — not just obesity and diabetes. -
Scientists reveal the surprising truth about coffee and blood pressure
Coffee may give your blood pressure a temporary jolt, but that doesn’t mean it’s secretly wrecking your heart. Researchers say caffeine can briefly raise blood pressure by stimulating your heart and tightening blood vessels, especially in people who don’t drink coffee regularly. But large studies involving hundreds of thousands of people found no strong evidence that moderate coffee drinking increases the risk of developing hypertension. In fact, coffee also contains natural compounds that may help blood vessels function better. -
The brain’s “feel good” chemical may be secretly fueling tinnitus
Scientists have uncovered evidence that serotonin — the same brain chemical boosted by many antidepressants — may actually worsen tinnitus. Using advanced light-based brain stimulation in mice, researchers identified a serotonin-driven circuit linked directly to tinnitus-like behavior. The findings may explain why some people experience louder ringing in their ears while taking SSRIs. -
Scientists discover why Ozempic works better for some people
Some people taking Ozempic-like diabetes drugs may be getting dramatically better results for a surprising reason: why they overeat in the first place. A year-long study in Japan found that people who tend to eat because tempting food looks or smells irresistible were much more likely to lose weight and improve blood sugar levels on GLP-1 medications. But people who eat mainly in response to stress, sadness, or emotional struggles didn’t see the same long-term benefits. -
This cheap drug could help people with type 1 diabetes use less insulin
A surprising new clinical trial has revealed that metformin—a cheap, century-old drug widely used for type 2 diabetes—may help people with type 1 diabetes in an unexpected way. While researchers initially hoped it would reduce insulin resistance, they instead found it allows patients to use about 12% less insulin while maintaining stable blood sugar levels. -
Why Ozempic doesn’t work for everyone: Scientists just found a hidden reason
A new study reveals that popular diabetes and weight-loss drugs like Ozempic and Wegovy may not work as effectively for about 10% of people due to specific genetic variants. These individuals appear to have a puzzling condition called “GLP-1 resistance,” where their bodies produce higher levels of the hormone targeted by these drugs—but don’t respond to it properly. -
Scientists reveal new blood pressure treatment that works when others fail
A new pill called baxdrostat is showing strong results in lowering dangerously high blood pressure in people who don’t respond to standard treatments. In a large global trial, patients saw their blood pressure drop by nearly 10 mmHg, a meaningful reduction that can significantly lower the risk of heart attack, stroke, and kidney disease. By targeting a hormone that causes the body to retain salt and water, this treatment could offer a much-needed solution for millions struggling with uncontrolled hypertension. -
A bold new plan could finally cure type 1 diabetes
Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with custom-engineered immune cells that protect them. The goal is to stop the immune system from destroying transplanted cells — without using immunosuppressive drugs. Backed by $1 million in funding, the team hopes to create a ready-to-use treatment that could work even for people who have had diabetes for years. The approach could transform how the disease is treated.